Absorption |
Blood-Brain Barrier | BBB+ | 0.6546 |
Human Intestinal Absorption | HIA+ | 0.9942 |
Caco-2 Permeability | Caco2+ | 0.7477 |
P-glycoprotein Substrate | Substrate | 0.5297 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9523 |
Non-inhibitor | 0.9381 |
Renal Organic Cation Transporter | Non-inhibitor | 0.8967 |
Distribution |
Subcellular localization | Mitochondria | 0.8757 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7351 |
CYP450 2D6 Substrate | Non-substrate | 0.8971 |
CYP450 3A4 Substrate | Non-substrate | 0.6694 |
CYP450 1A2 Inhibitor | Inhibitor | 0.9216 |
CYP450 2C9 Inhibitor | Inhibitor | 0.8498 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.7178 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.6800 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8146 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7417 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9434 |
Non-inhibitor | 0.9109 |
AMES Toxicity | AMES toxic | 0.9497 |
Carcinogens | Non-carcinogens | 0.8769 |
Fish Toxicity | High FHMT | 0.9655 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9844 |
Honey Bee Toxicity | High HBT | 0.6915 |
Biodegradation | Not ready biodegradable | 0.8205 |
Acute Oral Toxicity | II | 0.4970 |
Carcinogenicity (Three-class) | Non-required | 0.5154 |